| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |